GUGGENHIME ANDREW, PRESIDENT AND CFO at Vaxcyte, Inc., sold $121K of PCVX
This page documents an SEC Form 4 insider trading disclosure for $PCVX securities filed with the Securities and Exchange Commission. Section 16 of the Securities Exchange Act of 1934 mandates that corporate officers, directors, and beneficial owners of more than 10% of a company's registered equity securities must report their personal trades within two business days of execution. Insider transactions are closely monitored by market participants because insiders possess firsthand knowledge of company operations, financial condition, and near-term prospects. The transaction details below are drawn directly from the SEC EDGAR filing database and reflect the information as reported.
Transaction Details
| Insider | GUGGENHIME ANDREW |
|---|---|
| Title | PRESIDENT AND CFO |
| Company | Vaxcyte, Inc. |
| Ticker | PCVX |
| Transaction Type | Sale |
| Transaction Date | 2026-07-06 |
| Shares Traded | 2,087 |
| Price Per Share | $57.764 |
| Total Value | $121K |
| Filed Date | 2026-07-06 |
| Accession Number | 0001230724-26-000012 |
Ownership Context
| Shares Owned After Transaction | 104,395 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001230724-26-000012
Other Insider Trades — PCVX
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Dhaliwal Harpreet S. | Chief Technical Ops Officer | sold | $935K | 2026-08-05 |
| Dhaliwal Harpreet S. | Chief Technical Ops Officer | traded | $421K | 2026-08-05 |
| GUGGENHIME ANDREW | PRESIDENT AND CFO | sold | $374K | 2026-08-03 |
| GUGGENHIME ANDREW | PRESIDENT AND CFO | sold | $165K | 2026-08-03 |
| Wassil Jim | CHIEF OPERATING OFFICER | sold | $46K | 2026-08-03 |
| Wassil Jim | CHIEF OPERATING OFFICER | traded | $12K | 2026-08-03 |
| GUGGENHIME ANDREW | PRESIDENT AND CFO | traded | $54K | 2026-08-03 |
| Wassil Jim | CHIEF OPERATING OFFICER | sold | $75K | 2026-08-03 |
| PICKERING GRANT | CHIEF EXECUTIVE OFFICER, Director | traded | $33K | 2026-07-27 |
| PICKERING GRANT | CHIEF EXECUTIVE OFFICER, Director | sold | $654K | 2026-07-27 |
Other Trades by GUGGENHIME ANDREW
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| PCVX | Vaxcyte, Inc. | sold | $374K | 2026-08-03 |
| PCVX | Vaxcyte, Inc. | traded | $54K | 2026-08-03 |
| PCVX | Vaxcyte, Inc. | sold | $165K | 2026-08-03 |
| PCVX | Vaxcyte, Inc. | sold | $452K | 2026-07-06 |
| PCVX | Vaxcyte, Inc. | traded | $54K | 2026-07-06 |
| PCVX | Vaxcyte, Inc. | traded | $54K | 2026-06-18 |
| PCVX | Vaxcyte, Inc. | sold | $530K | 2026-06-18 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for PCVX — Vaxcyte, Inc. →
Whisper Score — PCVX
Track PCVX insider activity in real time on The Wire →
Get alerts when GUGGENHIME ANDREW files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: August 12, 2026 at 07:09 UTC